Clinical trial NCT06322615: Acupressure for Reducing Anxiety in Patients Undergoing Chemotherapy
Official title: Acupressure for Anxiety: A Pilot Study of a Nurse-Led Acupressure Intervention for Patients Receiving Chemotherapy
Study type: INTERVENTIONAL
Overall status: RECRUITING
Phase: NA
Conditions: Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm
Lead sponsor: Mayo Clinic
Sponsor class: OTHER
First posted: 2024-03-21
Enrollment: 30
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: SUPPORTIVE_CARE

Brief summary: This clinical trial evaluates whether acupressure is helpful to reduce anxiety related to chemotherapy. Anxiety is experienced by many patients with cancer. Anxiety can be related to chemotherapy and may contribute to other symptoms, such as nausea and poor quality of life. Some patients diagnosed with cancer express interest in non-medicinal ways to manage symptoms. Acupressure is a noninvasive intervention that can be used for many different symptoms. Acupressure is well tolerated with minimal reports of adverse reactions, making it a good choice for patients with cancer. This study may help researchers learn whether acupressure is useful for managing anxiety in patients undergoing chemotherapy.

Detailed description: PRIMARY OBJECTIVES:

I. Evaluate the feasibility of a nurse- and patient-applied acupressure intervention for patients with anxiety associated with active cancer-directed therapy.

II. Patient-reported changes in acute anxiety associated with both the nurse and self-led acupressure interventions will be ascertained.

OUTLINE:

Patients undergo acupressure over 15-120 seconds at a time for up to 15 minutes. After completion of the session, patients may optionally receive an education session on using acupressure at home.

After completion of study intervention, patients who opted to receive education about using acupressure at home are followed up at 1 week.

Eligibility criteria: Inclusion Criteria:

* Be over 18 years of age
* Be actively undergoing chemotherapy in the Mayo Clinic chemotherapy unit
* Report anxiety as a 1 or higher, on a scale from 0 (no anxiety) to 4 (severe anxiety)
* Be willing to undergo a short acupressure session

Exclusion Criteria:

* Does not meet the inclusion criteria

Primary outcomes:
measure: Number of patients approached about undergoing acupressure intervention (Feasibility)
timeFrame: Up to 1 year
measure: Number of patients interested in the initial acupressure intervention in the chemotherapy unit (Feasibility)
timeFrame: Up to 1 year
measure: Number of patients interested in the home acupressure intervention (Feasibility)
timeFrame: Up to 1 year
measure: Time taken for each nurse-led acupressure intervention in the chemotherapy unit (Feasibility)
timeFrame: Up to 1 year
measure: Patient-reported changes in acute anxiety
timeFrame: At baseline, after a one-time nurse-administered acupressure session, and after one week of self-administered acupressure sessions
Secondary outcomes:
Other outcomes:
Locations:
city: Rochester
country: United States
facility: Mayo Clinic in Rochester
state: Minnesota
Study officials:
affiliation: Mayo Clinic in Rochester
name: Laura S. Rhee, D.O.
role: PRINCIPAL_INVESTIGATOR
References: